fatty-liver

Documents about fatty-liver

• The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes#141198ClinicalTrials.gov
• Inverse Association Between Dietary Niacin Intake and Prevalence of Depressive Symptoms in Adults With Metabolic‐Associated Fatty Liver Disease: A Cross‐Sectional Study.#297473NCBI PubMed Central
• Microbiota-Derived Indole-3-Carboxaldehyde Exerts Sex-Specific Protective Effects in a Reverse Translational Mouse Model of Diet-Induced Obesity and Fatty Liver Disease#326384IBISS
• Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD#860207ClinicalTrials.gov
• A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.#862394ClinicalTrials.gov
• Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia#891863ClinicalTrials.gov
• To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation#1009686ClinicalTrials.gov
• Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)#846047ClinicalTrials.gov
• Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)#911479ClinicalTrials.gov
• A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)#968053ClinicalTrials.gov
• Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers#1046119ClinicalTrials.gov
• Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism#143880PLOS
• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus#162443ClinicalTrials.gov
• Prediction of Depression in Women With Metabolic Dysfunction-Associated Fatty Liver Disease Using Routine Blood Tests: A Five-Year Longitudinal Analysis From the UK Biobank.#351536NCBI PubMed Central
• Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis#460022ClinicalTrials.gov
• Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes#832934ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH#898878ClinicalTrials.gov
• Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH#623459ClinicalTrials.gov
• Quantifying Hepatic Mitochondrial Fluxes in Humans#828758ClinicalTrials.gov
• MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin#906707ClinicalTrials.gov
• Increased srum uric acid over five years is a risk factor for developing fatty liver#955297Koc University Digital Collections
• Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.#858903ClinicalTrials.gov
• Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI#801015ClinicalTrials.gov
• Disruption of G0/G1 switch gene 2 (G0S2) reduced abdominal fat deposition and altered fatty acid composition in chicken#447006S-Space: Seoul National University
• A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)#825312ClinicalTrials.gov
• Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study#855176ClinicalTrials.gov
• A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants#967379ClinicalTrials.gov
• Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN#158101ClinicalTrials.gov
• An interpretable machine learning model based on routine clinical indicators for early identification of obesity-related non-alcoholic fatty liver disease in children: a single-center retrospective study.#452877NCBI PubMed Central
• Regulation of FGF21 by Nutritional Challenges#802274ClinicalTrials.gov
• Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity#843254ClinicalTrials.gov
• Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese Subjects#848602ClinicalTrials.gov
• Observational Study of Early Metabolic and Vascular Changes in Obesity#881619ClinicalTrials.gov
• A System for In Vivo Imaging of Hepatic Free Fatty Acid Uptake#624317eScholarship
• The Effect of Protein-enriched Diet on Body Composition and Appetite#896979ClinicalTrials.gov
• A SPOONFUL OF SUGAR HELPS CHOLESTEROL GO DOWN: MECHANISMS OF GLUCOKINASE REGULATION AND ACTIVITY REGULATE HEPATIC INSULIN SENSITIVITY AND CHOLESTEROL SYNTHESIS#929281ScholarlyCommons
• Gut microbiota composition combined with reduced intestinal fatty acid uptake prevents hepatic steatosis in obesity-resistant mice fed a high-fat diet#448737IBISS
• Effect of Metformin and Valsartan Toward Homa-IR in Metabolic Syndrome Patient with Non-Alcoholic Fatty Liver Disease (NAFLD)#930408Acta Interna: The Journal of Internal Medicine
• Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: a transient elastography study#955524Koc University Digital Collections
• Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults#919007ClinicalTrials.gov
• Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis#1010899ClinicalTrials.gov
• Fatty Liver Imaging Project#914722ClinicalTrials.gov
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus#158186ClinicalTrials.gov
• A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers#836823ClinicalTrials.gov
• Body mass index modifies the association between occupational noise exposure duration and ultrasound‑detected hepatic steatosis: A cross-sectional study among male factory workers#686599PLOS
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients#811697ClinicalTrials.gov
• The Potential Prophylactic Effect of Moringa oleifera Lam. Leaf Extracts Against Fructose-Induced Metabolic Dysfunction in Early-Weaned Female Rats#1042055WIReDSpace
• Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).#866877ClinicalTrials.gov
• University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)#827409ClinicalTrials.gov
• A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD#873045ClinicalTrials.gov